Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Rapporto sulle azioni

Cap. di mercato: CN¥11.7b

Sunflower Pharmaceutical GroupLtd Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Yi Guan

Amministratore delegato

CN¥4.8m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.8yrs
Proprietà del CEOn/a
Durata media del management2.9yrs
Durata media del Consiglio di amministrazione3.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Aug 26
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Jul 19
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

AMMINISTRATORE DELEGATO

Yi Guan (42 yo)

5.8yrs

Mandato

CN¥4,800,000

Compensazione

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Yi Guan
GM & Non-Independent Director5.8yrsCN¥4.80mNessun dato
Chunhong Wu
Financial Manager2.9yrsCN¥774.90kNessun dato
Guangguang Zhou
Board Secretary2.8yrsCN¥436.70kNessun dato
Liang Chen
Deputy General Manager2.9yrsCN¥3.06mNessun dato
Jin Ming Lin
Deputy General Manager4.8yrsCN¥786.00kNessun dato
Xin Ma
Deputy General Manager2.9yrsCN¥1.36mNessun dato
Yang Hai
Deputy General Manager2.9yrsCN¥1.41mNessun dato

2.9yrs

Durata media

43yo

Età media

Gestione esperta: Il team dirigenziale di 002737 è considerato esperto (durata media dell'incarico 2.9 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Yi Guan
GM & Non-Independent Director7.2yrsCN¥4.80mNessun dato
Yanling Guan
Non-Independent Director10.7yrsCN¥1.18mNessun dato
Jingshang Ren
Non-Independent Director7.2yrsCN¥50.00kNessun dato
Yan He
Non-Employee Supervisor7.2yrsNessun datoNessun dato
Chunyan Na
Supervisor4.1yrsNessun datoNessun dato
Yuxiu Guan
Chairman5.8yrsCN¥1.20mNessun dato
Fen Lan
Chairman of the Supervisory Board2.7yrsNessun datoNessun dato
Jianzhong Zhou
Non-Independent Directorless than a yearNessun datoNessun dato
Yang Yang
Non-Independent Directorless than a yearNessun datoNessun dato
Jiajun Miao
Independent Directorless than a yearNessun datoNessun dato
Ying Zhang
Independent Directorless than a yearNessun datoNessun dato
Yan Zhao
Independent directorless than a yearNessun datoNessun dato

3.4yrs

Durata media

46yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 002737 sono considerati esperti (durata media dell'incarico 3.4 anni).